Loading...
Acetyl-CoA Counteracts the Inhibitory Effect of Antiandrogens on Androgen Receptor Signaling in Prostate Cancer Cells
Makhov, Peter ; Fazliyeva, Rushaniya ; Tufano, Antonio ; ; Cai, Kathy Q. ; Serebriiskii, Ilya ; ; Andrews, Andrew J. ; Kolenko, Vladimir M.
Makhov, Peter
Fazliyeva, Rushaniya
Tufano, Antonio
Cai, Kathy Q.
Serebriiskii, Ilya
Andrews, Andrew J.
Kolenko, Vladimir M.
Citations
Altmetric:
Genre
Journal article
Date
2022-11-29
Advisor
Committee member
Department
Cardiovascular Sciences
Cancer and Cellular Biology
Cancer and Cellular Biology
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.3390/cancers14235900
Abstract
The commonly used therapeutic management of PC involves androgen deprivation therapy (ADT) followed by treatment with AR signaling inhibitors (ARSI). However, nearly all patients develop drug-resistant disease, with a median progression-free survival of less than 2 years in chemotherapy-naïve men. Acetyl-coenzyme A (acetyl-CoA) is a central metabolic signaling molecule with key roles in biosynthetic processes and cancer signaling. In signaling, acetyl-CoA serves as the acetyl donor for acetylation, a critical post-translational modification. Acetylation affects the androgen receptor (AR) both directly and indirectly increasing expression of AR dependent genes. Our studies reveal that PC cells respond to the treatment with ARSI by increasing expression of ATP-citrate lyase (ACLY), a major enzyme responsible for cytosolic acetyl-CoA synthesis, and up-regulation of acetyl-CoA intracellular levels. Inhibition of ACLY results in a significant suppression of ligand-dependent and -independent routes of AR activation. Accordingly, the addition of exogenous acetyl-CoA, or its precursor acetate, augments AR transcriptional activity and diminishes the anti-AR activity of ARSI. Taken together, our findings suggest that PC cells respond to antiandrogens by increasing activity of the acetyl-coA pathway in order to reinstate AR signaling.
Description
Citation
Makhov, P.; Fazliyeva, R.; Tufano, A.; Uzzo, R.G.; Cai, K.Q.; Serebriiskii, I.; Snyder, N.W.; Andrews, A.J.; Kolenko, V.M. Acetyl-CoA Counteracts the Inhibitory Effect of Antiandrogens on Androgen Receptor Signaling in Prostate Cancer Cells. Cancers 2022, 14, 5900. https://doi.org/10.3390/cancers14235900
Citation to related work
MDPI
Has part
Cancers, Vol. 14, Iss. 23
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
